Caprolactam Chemicals Ltd discloses non-applicability of Related Party Transaction regulations for FY26
Caprolactam Chemicals Ltd informed BSE that it is exempt from Related Party Transaction disclosures under Regulation 23(9) of SEBI LODR Regulations, 2015 for FY26, as its paid-up equity share capital of Rs. 4,60,00,000 and net worth of Rs. 4,95,89,569 as on March 31, 2025, are below the threshold limits of Rs. 10 crore and Rs. 25 crore respectively.

*this image is generated using AI for illustrative purposes only.
Caprolactam Chemicals Ltd has submitted a disclosure to BSE Limited regarding the non-applicability of Regulation 23(9) of the SEBI (LODR) Regulations, 2015, which mandates the disclosure of Related Party Transactions. The communication, dated April 22, 2026, was addressed to the stock exchange from Mumbai.
The company cited Regulation 15(2) of the SEBI (LODR) Regulations, 2015, which exempts listed entities from complying with corporate governance provisions under various regulations, including Regulation 23(9). This exemption applies to companies whose paid-up equity share capital does not exceed rupees ten crore and whose net worth does not exceed rupees twenty-five crore as on the last day of the previous financial year.
Financial Position as on March 31, 2025
| Parameter | Amount |
|---|---|
| Paid-up Equity Share Capital | Rs. 4,60,00,000 |
| Net Worth | Rs. 4,95,89,569 |
Based on these figures, Caprolactam Chemicals Ltd confirmed that it is not required to submit Related Party Transaction disclosures as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015. The company requested BSE Limited to take this information on record.
The disclosure was signed by the Company Secretary on behalf of Caprolactam Chemicals Limited. The company's BSE code is 507486.
Historical Stock Returns for Caprolactam Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -4.49% | +13.47% | +11.67% | +8.48% | +59.81% |
Will Caprolactam Chemicals' exemption status affect investor confidence given the reduced transparency requirements?
How might the company's growth plans be impacted by the need to maintain its size below exemption thresholds?
What are the potential risks for minority shareholders when related party transaction disclosures are not mandatory?
































